Ikarian Capital, LLC - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q2 2022$1,337,000
-4.8%
830,007
-0.1%
0.24%
+31.9%
Q1 2022$1,404,000
-9.9%
830,747
+5.0%
0.18%
-20.3%
Q4 2021$1,558,000
-3.9%
790,8380.0%0.23%
+103.5%
Q3 2021$1,622,000
-15.3%
790,838
-1.2%
0.11%
-26.5%
Q2 2021$1,915,000
+19.6%
800,8110.0%0.16%
+187.0%
Q1 2021$1,601,000800,8110.05%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$4,382,0001.02%
Telemetry Investments, L.L.C. 75,000$127,0000.20%
Ikarian Capital, LLC 830,747$1,404,0000.18%
DLD Asset Management, LP 550,000$930,0000.06%
Phoenix Holdings Ltd. 1,020,000$1,724,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$27,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$135,0000.00%
HBK Sorce Advisory LLC 22,325$38,0000.00%
B. Riley Wealth Management, Inc. 12,000$20,0000.00%
TWO SIGMA SECURITIES, LLC 12,155$21,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders